ezetimibe has been researched along with tetradecanoylphorbol acetate in 1 studies
Studies (ezetimibe) | Trials (ezetimibe) | Recent Studies (post-2010) (ezetimibe) | Studies (tetradecanoylphorbol acetate) | Trials (tetradecanoylphorbol acetate) | Recent Studies (post-2010) (tetradecanoylphorbol acetate) |
---|---|---|---|---|---|
2,484 | 563 | 1,465 | 31,050 | 61 | 2,217 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cachofeiro, V; Fernández-Cruz, A; Gómez-Garre, D; Miana, M; Muñoz-Pacheco, P; Ortega-Hernández, A | 1 |
1 other study(ies) available for ezetimibe and tetradecanoylphorbol acetate
Article | Year |
---|---|
Ezetimibe inhibits PMA-induced monocyte/macrophage differentiation by altering microRNA expression: a novel anti-atherosclerotic mechanism.
Topics: Anticholesteremic Agents; Atherosclerosis; Azetidines; Cell Adhesion; Cell Culture Techniques; Cell Differentiation; Cell Line; Ezetimibe; Flow Cytometry; Humans; Macrophages; MicroRNAs; Monocytes; NF-kappa B; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Tetradecanoylphorbol Acetate | 2012 |